The role of SDF-1α in cerebral ischemic injury is complex since some studies have shown positive effects of SDF-1α in the acute phase after stroke [23, 24] whereas other studies have demonstrated positive effects by blocking the SDF-1α/CXCR4 pathway in the recovery phase after stroke [25, 26]. The gene discussed is CXCR4; the disease is stroke disorder.